Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Therapie|September 14, 2004
Pharmacokinetics-pharmacodynamics during drug development--an example from Servier: ivabradineChristian Laveille, Roeline Jochemsen
Rheumatology and Therapy|April 25, 2024
Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated AnalysisPatrick Brossard, Christian Laveille
Clinical Pharmacokinetics|March 15, 2017
Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed EpilepsyAndreas Lindauer, Christian Laveille, Armel Stockis
Journal of Clinical Pharmacology|October 15, 2013
A drug and disease model for lixisenatide, a GLP-1 receptor agonist in type 2 diabetesJustin J Wilkins, Michel Dubar, Bernard Sébastien, et al.
Pharmaceutical Research|August 15, 2006
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazideKarl Brendel, Emmanuelle Comets, Céline Laffont, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 8, 2006
Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysisAnnabelle Lemenuel-Diot, Christian Laveille, Nicolas Frey, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 13, 2005
Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trialMarylore Chenel, Kayode Ogungbenro, Vincent Duval, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 12, 2007
Evaluation of uncertainty parameters estimated by different population PK software and methodsCéline Dartois, Annabelle Lemenuel-Diot, Christian Laveille, et al.
Pageof 2